Biodexa Pharmaceuticals (BDRX) Other Non Operating Income (2015 - 2020)
Biodexa Pharmaceuticals (BDRX) posted Other Non Operating Income of $88149.6 for Q3 2020, down 98.22% sequentially from $4.9 million in Q4 2018.
Biodexa Pharmaceuticals (BDRX) Other Non Operating Income (2015 - 2020) Analysis & Trends
Biodexa Pharmaceuticals has reported Other Non Operating Income for 3 years, with the latest figure at $88149.6 in Q3 2020.
- Quarterly Other Non Operating Income changed N/A year-over-year to $88149.6 in Q3 2020, while the trailing twelve-month figure through Dec 2018 was $4.9 million (changed N/A YoY) and the FY2025 annual result came in at -$171406.3, down 3438.65% from the prior year.
- Other Non Operating Income retreated to $88149.6 in Q3 2020 per BDRX's latest filing, from $4.9 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $4.9 million in Q4 2018 and troughed at $88149.6 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biodexa Pharmaceuticals | 64,325.41 | -11.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 10, 2020 | 88,149.63 |
| Dec 31, 2018 | 4.94 Mn |
| Dec 31, 2015 | -250,385.94 |